Business | Press Trust of India | Tuesday April 26, 2016
The Delhi High Court has allowed pharmaceutical firms Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and HERTRAZ.
www.ndtv.com/business